Biotech · Private company
AVROBIO
Track this companyFree. Adds AVROBIO to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- AVR-RD-01Phase 2 · Fabry DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- AVR-RD-02Phase 2 · Gaucher DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Safety and efficacy assessmentsType 1 Gaucher DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Long-Term Follow-up Study of Subjects With Gaucher Disease Who Previously Received AVR-RD-02TERMINATED · started Jul 6, 2021ClinicalTrials.gov NCT04836377 · fetched Nov 12, 2026
- Lentiviral Vector Gene Therapy - The Guard1 Trial of AVR-RD-02 for Subjects With Type 1 Gaucher DiseasePHASE1_PHASE2 · TERMINATED · started May 30, 2019ClinicalTrials.gov NCT04145037 · fetched Nov 12, 2026
- Open Label, Study Of Efficacy and Safety Of AVR-RD-01 for Treatment-Naive Subjects With Classic Fabry DiseasePHASE1_PHASE2 · TERMINATED · started Feb 21, 2018ClinicalTrials.gov NCT03454893 · fetched Nov 12, 2026